Introduction

Two Democratic lawmakers, Representatives Kathy Castor of Florida and Terri Sewell of Alabama, have introduced a bill aimed at reversing a recent decision by the Trump administration. This bill seeks to continue a Medicare prescription drug subsidy program through 2029, known as the Affordable Premiums for Seniors Act.

Bill Purpose

The legislation proposes the extension of the Medicare Part D Premium Stabilization Demonstration beyond 2026. This comes in response to an announcement by the Centers for Medicare & Medicaid Services (CMS) about the termination of the program at the end of the next year. Representative Castor commented on the issue, stating that the high cost of prescription drugs adds to the financial strain on seniors. She stressed that seniors deserve affordable and dependable Medicare benefits.

Why the Extension Matters

Data from 2026 shows nearly 25 million people enrolled in standalone Medicare Part D prescription drug plans. Without the stabilization program, beneficiaries could face significant premium increases in 2027. Seniors living on fixed incomes already struggle with rising housing and healthcare costs. Retaining the subsidy may help keep drug coverage affordable despite contrasting views from the Trump administration.

Legislative Impact

If passed, the Affordable Premiums for Seniors Act will prevent CMS from ending the subsidy program and continue it through 2029. The subsidy was initially created after changes under the Inflation Reduction Act, which included capping out-of-pocket drug costs to $2,000 annually and altering cost-sharing in Part D plans.

“Ending the Premium Stabilization Program removes a cushion protecting insurers from major changes in Medicare Part D,” said Michael Ryan, finance expert.

Ryan highlighted the program’s success in keeping premium increases manageable and providing predictable costs for seniors. An increase of even $10 to $20 affects those living on fixed incomes significantly.

Proposed Benefits

• Extends Medicare Part D Premium Stabilization Demonstration through 2029.
• Preserves federal premium assistance for standalone Medicare Part D plans.
• Aims to keep premiums lower, reversing Trump’s planned termination.

Kevin Thompson, CEO of 9i Capital Group, acknowledged the benefits of lowering premiums for low-income beneficiaries but questioned subsidizing insurers instead of addressing overall prescription drug costs.

Financial Impact

According to the Medicare Payment Advisory Commission, the subsidy saved seniors $312 in 2026. Representative Sewell emphasized the importance of continuing the program as a measure to reduce financial strain on seniors.

“The Trump Administration should do everything to lower costs, not end programs that help seniors afford prescriptions,” Sewell said.

Administration’s Standpoint

CMS announced the program’s end after planning for 2027. Mehmet Oz, CMS administrator, argued the subsidies were no longer necessary as insurers adapted to Medicare Part D’s redesign. He stated, “We are stabilizing the market.” According to CMS, most premiums will rise by less than $10, some may even decrease.

Oz also stressed the demonstration was initially temporary and extending it could shift costs back to taxpayers, delaying normal market pricing.

Future Steps

The bill faces challenges within a Republican-controlled Congress and requires approval from both chambers. Medicare beneficiaries await the 2027 premium announcements for better clarity on how costs may develop without the stabilization program.

“Democrats lack the votes and need bipartisan support to extend subsidy,” Thompson noted.